Methods and systems for presenting an inhalation experience

• US 20100163038A1
• Filed: 04/30/2009
• Published: 07/01/2010
• Est. Priority Date: 12/30/2008
• Status: Abandoned Application

• Current Assignee: Gearbox LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Tegreene, Clarence T., Langer, Robert, Lord, Robert W., Wood, Lowell L. JR., Hyde, Roderick A., Sweeney, Elizabeth A., Leuthardt, Eric C.
• Application Number:
  US12/387,321
• Publication Number:
  US 20100163038A1
• Time in Patent Office: Days
• US Class Current: 128/203.140
• CPC Class Codes: A61B 5/01 Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue clinical contact thermometers G01K13/20
• CPC Class Codes: A61B 5/02 Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
• CPC Class Codes: A61B 5/024 Detecting, measuring or recording pulse rate or heart rate A61B5/0205, A61B5/021 take precedence
• CPC Class Codes: A61B 5/11 Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb for measuring pulse A61B5/02 ;A61B5/1038 takes precedence; motion detection to correct for motion artifacts in physiological signals A61B5/721
• CPC Class Codes: A61B 5/145 Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissuemeasuring of blood pressure or blood flow A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/165 Evaluating the state of mind, e.g. depression, anxiety
• CPC Class Codes: A61B 5/377 using evoked responses
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/4833 Assessment of subject's compliance to treatment
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/486 Bio-feedback A61B5/375 takes precedence
• CPC Class Codes: A61B 5/6822 Neck
• CPC Class Codes: A61M 11/00 Sprayers or atomisers specially adapted for therapeutic purposes in general B05B; aerosol containers B65D83/14
• CPC Class Codes: A61M 15/00 Inhalators drug delivery in endotracheal tubes A61M16/04
• CPC Class Codes: A61M 15/0028 using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
• CPC Class Codes: A61M 15/0065 Inhalators with dosage or measuring devices A61M15/0028 takes precedence; dosage devices incorporated in aerosol cans B65D83/52
• CPC Class Codes: A61M 15/009 using medicine packages with incorporated spraying means, e.g. aerosol cans pocket atomiser of the injector type A61M11/08
• CPC Class Codes: A61M 15/02 with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
• CPC Class Codes: A61M 15/08 Inhaling devices inserted into the nose
• CPC Class Codes: A61M 2021/0016 : by the smell sense
• CPC Class Codes: A61M 2205/3553 : remote, e.g. between patient's home and doctor's office
• CPC Class Codes: A61M 2205/3569 : sublocal, e.g. between console and disposable
• CPC Class Codes: A61M 2205/3584 : using modem, internet or bluetooth
• CPC Class Codes: A61M 2205/3592 : using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: A61M 2205/50 : with microprocessors or computers
• CPC Class Codes: A61M 2205/581 : by audible feedback
• CPC Class Codes: A61M 2205/582 : by tactile feedback
• CPC Class Codes: A61M 2205/583 : by visual feedback
• CPC Class Codes: A61M 2205/588 : by olfactory feedback, i.e. smell
• CPC Class Codes: A61M 2209/088 : on the body
• CPC Class Codes: A61M 2230/201 : Glucose concentration
• CPC Class Codes: A61M 2230/205 : partial oxygen pressure (P-O2)
• CPC Class Codes: A63F 2300/65 : for computing the condition of a game character
• CPC Class Codes: A63F 2300/6692 : using special effects, generally involving post-processing, e.g. blooming
• CPC Class Codes: G16H 20/13 : delivered from dispensers

Abstract

Methods, computer program products, and systems are described that include accepting an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual and presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual.

Claims

1. A computer-implemented method, comprising:

accepting an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual; and

presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual.

2-43. -43. (canceled)

44. A system, comprising:

means for accepting an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual; and

means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual.

45. The system of claim 44, wherein the means for accepting an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual comprises:

means for accepting an inhalation device-dispensed bioactive agent time schedule.

46. The system of claim 44, wherein the means for accepting an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual comprises:

means for accepting at least one of an inhalation device-dispensed bioactive agent delivery type or inhalation device-dispensed bioactive agent delivery dosage administration schedule.

47. The system of claim 44, wherein the means for accepting an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual comprises:

means for accepting an inhalation device-dispensed bioactive agent loading dose.

48. The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual comprises:

means for utilizing an algorithm for recommending at least one artificial sensory experience.

52. The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual comprises:

means for presenting an indication of an artificial sensory experience at least partly based on a personal medical history.

53. The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual comprises:

means for presenting an indication of an artificial sensory experience at least partly based on experimental data.

54. The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual comprises:

means for presenting an indication of an artificial sensory experience at least partly based on a medical reference tool.

55. The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual comprises:

means for presenting the indication to at least one output device.

58. The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual comprises:

means for presenting the indication to a third party.

59. The system of claim 58, wherein the means for presenting the indication to a third party comprises:

means for presenting the indication to a health care provider.

60. The system of claim 58, wherein the means for presenting the indication to a third party comprises:

means for selectively presenting the indication only to the individual.

61. The system of claim 44, wherein the means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual comprises:

means for presenting an indication of a prescribed artificial sensory experience.

62. The system of claim 61, wherein the means for presenting an indication of a prescribed artificial sensory experience comprises:

means for presenting an indication of at least one effect of the prescribed artificial sensory experience.

65. The system of claim 61, wherein the means for presenting an indication of a prescribed artificial sensory experience comprises:

means for presenting an indication of at least one time period of an expected change in inhalation device-dispensed bioactive agent effectiveness.

66. The system of claim 61, wherein the means for presenting an indication of a prescribed artificial sensory experience comprises:

means for presenting an indication of at least one time period of an expected change in inhalation device-dispensed bioactive agent blood concentration.

67. The system of claim 61, wherein the means for presenting an indication of a prescribed artificial sensory experience comprises:

means for recommending an artificial sensory experience administration schedule.

68. The system of claim 44, wherein the means for accepting an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual and means for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual comprises:

means for accepting the pharmacokinetic profile of an inhaled bronchodilator, accepting a prescribed administration schedule of the inhaled bronchodilator to an individual, and presenting a prescription for engagement of the individual with a virtual world experience at times when the plasma concentration of the inhaled bronchodilator is expected to be below a substantially effective level based on the pharmacokinetic profile of the inhaled bronchodilator and the prescribed administration schedule of the inhaled bronchodilator.

69. The system of claim 44, further comprising:

means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of an inhalation device-dispensed bioactive agent.

70. The system of claim 69, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of an inhalation device-dispensed bioactive agent comprises:

means for accepting an indication of a time versus concentration representation for an inhalation device-dispensed bioactive agent.

71. The system of claim 69, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of an inhalation device-dispensed bioactive agent comprises:

means for accepting an indication of a dose versus response representation for the inhalation device-dispensed bioactive agent.

72. The system of claim 69, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of an inhalation device-dispensed bioactive agent comprises:

means for accepting a depiction of an area under plasma concentration versus time curve for the inhalation device-dispensed bioactive agent.

73. The system of claim 69, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of an inhalation device-dispensed bioactive agent comprises:

means for accepting a bioavailability profile for the inhalation device-dispensed bioactive agent.

74. The system of claim 69, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of an inhalation device-dispensed bioactive agent comprises:

means for accepting a pharmacokinetic model.

78. The system of claim 69, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of an inhalation device-dispensed bioactive agent comprises:

means for accepting pharmacokinetic profile information for an inhalation device-dispensed bioactive agent including at least one of an absorption characteristic, a distribution characteristic, a metabolization characteristic, or an excretion characteristic.

79. The system of claim 69, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of an inhalation device-dispensed bioactive agent comprises:

means for accepting an indication of a pharmacokinetic profile at least partly based on at least one attribute of the individual.

80. The system of claim 79, wherein the means for accepting an indication of a pharmacokinetic profile at least partly based on at least one attribute of the individual comprises:

means for accepting an indication of a pharmacokinetic profile at least partly based on at least one of a vital sign, organ function, weight, hepatic failure, hydration level, sex, or age.

83. The system of claim 69, wherein the means for accepting an indication of at least one of a pharmacokinetic or pharmacodynamic profile of an inhalation device-dispensed bioactive agent comprises:

means for accepting at least one of a Tmin, Tmax, Cmin, or a Cmax value for the inhalation device-dispensed bioactive agent.

49-51. -51. (canceled)

56-57. -57. (canceled)

63-64. -64. (canceled)

75-77. -77. (canceled)

81-82. -82. (canceled)

84-86. -86. (canceled)

87. A system, comprising:

circuitry for accepting an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual; and

circuitry for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual.

88. A computer program product comprising:

a signal-bearing medium bearing

one or more instructions for accepting an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual; and

one or more instructions for presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual.

89. The computer program product of claim 88, wherein the signal-bearing medium includes a computer-readable medium.

90. The computer program product of claim 88, wherein the signal-bearing medium includes a recordable medium.

91. The computer program product of claim 88, wherein the signal-bearing medium includes a communications medium.

92. A system comprising:

a computing device; and

instructions that when executed on the computing device cause the computing device to

accept an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual; and

present an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual.

93. The system of claim 92 wherein the computing device comprises:

one or more of a personal digital assistant (PDA), a personal entertainment device, a mobile phone, a laptop computer, a tablet personal computer, a networked computer, a computing system comprised of a cluster of processors, a computing system comprised of a cluster of servers, a workstation computer, and/or a desktop computer.

94. The system of claim 92, wherein the computing device is operable to accept the at least one attribute of the at least one individual and present the indication of the at least one prescription medication and the at least one artificial sensory experience from at least one memory.